Advertisement

HIV: Identification, Diagnosis, and Prevention

  • Gunter Rieg
Chapter
Part of the Current Clinical Practice book series (CCP)

Abstract

Over the last 30 years, advances in the understanding and treatment of HIV infected ranks among the most remarkable in medical history. While the rate of new HIV infections in the United States remain at a high level, advanced treatment options make HIV infection a manageable disease.

Sexual transmission of HIV remains the main mode of acquiring HIV. Men who have sex with men is the most affected group, while minorities are disproportionally affected. The risk of transmission through sexual contact ranges from 4 to 170 per 10,000 sex acts. Condoms and other barrier methods are the most commonly used prevention tool; in addition, the FDA recently approved Truvada, a co-formulated tablet containing two antiretroviral agents, for pre-exposure prophylaxis.

Prevention and diagnosis are important interventions to curb the HIV epidemic. HIV testing is considered an important routine test for all persons age 13–64 with health-care contacts. During the HIV testing “window period,” suspicion for a newly acquired HIV infection is required given the nonspecific symptoms of acute HIV infection.

Keywords

Human Immunodeficiency Virus Human Immunodeficiency Virus Infection Anal Intercourse Acquire Immune Deficiency Syndrome Human Immunodeficiency Virus Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Centers for Disease Control and Prevention. HIV/AIDS surveillance report, Vol. 22; 2010. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention. Available from: http://www.cdc.gov/hiv/stats/hasrlink.htm. Accessed 21 July 2012.
  2. 2.
    Clemetson DB, Moss GB, Willerford DM, et al. Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA. 1993;269:2860–4.PubMedCrossRefGoogle Scholar
  3. 3.
    Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet. 1997;350:922–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Vernazza PL, Eron JJ, Fiscus SA, Cohen MS. Sexual transmission of HIV: infectiousness and prevention. AIDS. 1999;13:155–66.PubMedCrossRefGoogle Scholar
  5. 5.
    Bagasra O, Farzadegan H, Seshamma T, Oakes JW, Saah A, Pomerantz RJ. Detection of HIV-1 proviral DNA in sperm from HIV-1-infected men. AIDS. 1994;8:1669–74.PubMedCrossRefGoogle Scholar
  6. 6.
    Bujan L, Pasquier C, Labeyrie E, Lanusse-Crousse P, Morucci M, Daudin M. Insemination with isolated and virologically tested spermatozoa is a safe way for human immunodeficiency type 1 virus-serodiscordant couples with an infected male partner to have a child. Fertil Steril. 2004;82:857–62.PubMedCrossRefGoogle Scholar
  7. 7.
    Pasquier C, Daudin M, Righi L, et al. Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children. AIDS. 2000;14:2093–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Krieger JN, Nirapathpongporn A, Chaiyaporn M, et al. Vasectomy and human immunodeficiency virus type 1 in semen. J Urol. 1998;159:820–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Tachet A, Dulioust E, Salmon D, et al. Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS. 1999;13:823–31.PubMedCrossRefGoogle Scholar
  10. 10.
    Zuckerman RA, Whittington WL, Celum CL, et al. Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy. J Infect Dis. 2004;190:156–61.PubMedCrossRefGoogle Scholar
  11. 11.
    Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 1996;381:667–73.PubMedCrossRefGoogle Scholar
  12. 12.
    Royce RA, Sena A, Cates Jr W, Cohen MS. Sexual transmission of HIV. N Engl J Med. 1997;336:1072–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Boily MC, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis. 2009;9(2):118–29.PubMedCrossRefGoogle Scholar
  14. 14.
    Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis. 2002;29:38–43.PubMedCrossRefGoogle Scholar
  15. 15.
    Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001;357:1149–53.PubMedCrossRefGoogle Scholar
  16. 16.
    Downs AM, DeVincenzi I. Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European Study Group in Heterosexual Transmission of HIV. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11:388–95.PubMedCrossRefGoogle Scholar
  17. 17.
    Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al.; Centers for Disease Control and Prevention (CDC). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1–17.Google Scholar
  18. 18.
    Iweala OI. HIV diagnostic tests: an overview. Contraception. 2004;70:141–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Mylonakis E, Paliou M, Lally M, Flanigan TP, Rich JD. Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches. Am J Med. 2000;109:568–76.PubMedCrossRefGoogle Scholar
  20. 20.
    Sudarshi D, Pao D, Murphy G, Parry J, Dean G, Fisher M. Missed opportunities for diagnosing primary HIV infection. Sex Transm Infect. 2008;84(1):14–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect. 1999;31:272–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Golombok S, Sheldon J. Evaluation of a thicker condom for use as a prophylactic against HIV transmission. AIDS Educ Prev. 1994;6:454–8.PubMedGoogle Scholar
  23. 23.
    Golombok S, Harding R, Sheldon J. An evaluation of a thicker versus a standard condom with gay men. AIDS. 2001;15:245–50.PubMedCrossRefGoogle Scholar
  24. 24.
    Mitchell HS, Stephens E. Contraception choice for HIV positive women. Sex Transm Infect. 2004;80:167–73.PubMedCrossRefGoogle Scholar
  25. 25.
    Karim AQ, Karim SSA, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. and on behalf of the CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.Google Scholar
  26. 26.
    Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995;346:530–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Panlilio AL, Cardo DM, Grohskopf LA, Heneine W, Ross CS. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR. 2005;54(RR09):1–17.PubMedGoogle Scholar
  28. 28.
    Smith DK, Grohskopf LA, Black RJ, Auerback JD, Veronese F, Struble KA, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. MMWR. 2005;54(RR02):1–20.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Kaiser Permanente Medical Group, Medicine DepartmentDavid Geffen School of Medicine at UCLAHarbor CityUSA
  2. 2.Department of Medicine, Division of Infectious DiseasesKaiser Permanente South Bay Medical CenterHarbor CityUSA

Personalised recommendations